Literature DB >> 3520939

Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies.

F Brosstad, I Kjønniksen, B Rønning, H Stormorken.   

Abstract

A method for visualization of the multimeric forms of von Willebrand Factor (vWF) in plasma and platelets is described. The method is based upon: 1) Separation of the vWF multimers by SDS-agarose electrophoresis, 2) Subsequent blotting of the vWF multimers onto nitrocellulose, 3) Immunolocalization and visualization of the vWF pattern by the sequential incubation of the blot with primary vWF antiserum, peroxidase- or beta-galactosidase-conjugated secondary antibodies and a relevant chromogenic substrate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3520939

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Analysis of von Willebrand factor multimers using a commercially available enhanced chemiluminescence kit.

Authors:  A M Cumming; R T Wensley
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

2.  Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity.

Authors:  M Anvret; M Blombäck; M Lindstedt; E Söderlind; M Tapper-Persson; A C Thelander
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

3.  Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count.

Authors:  P J van Genderen; J J Michiels; S C van der Poel-van de Luytgaarde; H H van Vliet
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

4.  ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?

Authors:  M C Kappers-Klunne; J G van Asten; H H van Vliet
Journal:  Ann Hematol       Date:  2009-02-11       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.